Education
About Us
Working with TipRanks
Follow Us
Lite Strategy (LITS)
NASDAQ:LITS
LITS Stock Chart & Stats
$1.33
--
Market closed
$1.33
--
Day’s Range― - ―
52-Week Range$0.95 - $9.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)622.79K
Market Cap
$38.61M
Enterprise Value$27.76M
Total Cash (Recent Filing)$10.11M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.82
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding36,769,676
10 Day Avg. Volume591,066
30 Day Avg. Volume622,792
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.78
Price to Sales (P/S)0.00
P/FCF Ratio-1.45
Enterprise Value/Market Cap0.72
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-7.63
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lite Strategy News
LITS FAQ
What was Lite Strategy’s price range in the past 12 months?
Lite Strategy lowest stock price was $0.95 and its highest was $9.00 in the past 12 months.
What is Lite Strategy’s market cap?
Lite Strategy’s market cap is $38.61M.
When is Lite Strategy’s upcoming earnings report date?
Lite Strategy’s upcoming earnings report date is May 07, 2026 which is in 84 days.
How were Lite Strategy’s earnings last quarter?
Currently, no data Available
Is Lite Strategy overvalued?
According to Wall Street analysts Lite Strategy’s price is currently Overvalued.
Does Lite Strategy pay dividends?
Lite Strategy pays a Notavailable dividend of $1.75 which represents an annual dividend yield of N/A. See more information on Lite Strategy dividends here
What is Lite Strategy’s EPS estimate?
Lite Strategy’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lite Strategy have?
Lite Strategy has 36,769,676 shares outstanding.
What happened to Lite Strategy’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lite Strategy?
Currently, no hedge funds are holding shares in LITS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Lite Strategy Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 64.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $826.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 0.7%
Last 30 Days ▲ 13.3%
Last 30 Days ▲ 13.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.39%
12-Months-Change
Fundamentals
Return on Equity
-16.88%
Trailing 12-Months
Asset Growth
308.42%
Trailing 12-Months
Company Description
Lite Strategy
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Technical Analysis
ABVC BioPharma
―
Jasper Therapeutics
―
Prelude Therapeutics
―
Gain Therapeutics
―
Estrella Immunopharma
―
Ownership Overview
10.47% Insiders
2.34% Mutual Funds
<0.01% Other Institutional Investors
84.84% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---